Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JJB van Lanschot
Neoadjuvant Selective COX-2 Inhibition Downregulates Important Oncogenic Pathways in Patients With Esophageal Adenocarcinoma
European Journal of Gastroenterology and Hepatology
Hepatology
Gastroenterology
Related publications
Vitamin D Receptor Expression and Neoadjuvant Therapy in Esophageal Adenocarcinoma
Experimental and Molecular Pathology
Forensic Medicine
Pathology
Clinical Biochemistry
Molecular Biology
Progression of Pancreatic Adenocarcinoma Is Significantly Impeded With a Combination of Vaccine and COX-2 Inhibition
Journal of Immunology
Allergy
Immunology
Prognostic Significance of Cyclooxygenase-2 (COX-2) Expression in Patients With Surgically Resectable Adenocarcinoma of the Oesophagus
BMC Cancer
Cancer Research
Oncology
Genetics
Esophageal Adenocarcinoma in a First-Degree Relative Increases Risk for Esophageal Adenocarcinoma in Patients With Barrett’s Esophagus
United European Gastroenterology Journal
Oncology
Gastroenterology
Long-Term Remission Following Treatment With Radiotherapy and Selective COX-2 Inhibitor in Two Dogs With Mandibular Salivary Gland Adenocarcinoma
Journal of the Japan Veterinary Medical Association
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
Archives of Internal Medicine
Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation
Trends in Pharmacological Sciences
Toxicology
Pharmacology
Viscum Album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
PLoS ONE
Multidisciplinary
Salvage Endoscopic Resection in Patients With Esophageal Adenocarcinoma After Chemoradiotherapy
Endoscopy International Open
